Promising Companies

Also showing items for Promising Research

 
Stock Quotes for Promising Companies top ^
  • Industry: Data Storage
  • Sector: Technology
  • Stock Style: Small Growth
Sign-up for 3057 investment picks

 
News Articles for Promising Companies top ^
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G024431-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/10/22/11G024431/convertedPNGlogo-845486396.jpg WASHINGTON, DC--(Marketwired - October 23, 2014) - American Jobs for America's Heroes (AJAH) , a non-profit military hiring campaign coordinated between the National Guard, private sector employers, trade associations, and the non-profit community, today presented the first annual "Delivering on the Promise Honor Roll Award" for outstanding commitment and leadership to 15 National Guard, employer, trade association and non-profit organizations that have made a substantial effort in helping National Guard members and veterans gain civilian employment (see more below). The awards ceremony, held at the National Guard Association of the U.S. headquarters in Washington, DC, recognized, "consistent dedication, specific achievement, and
Sign-up for "Delivering on the Promise: Jobs for National Guard and Veterans" investment picks
http://media.marketwire.com/attachments/201404/243780_Peregrine_logo_CMYK_sanspharm.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1155133&ProfileId=051205&sourceType=1 TUSTIN, CA --
Sign-up for Promising Data Presented at the Chicago Multidisciplinary Symposium on Thoracic Oncology From an Investigator-Sponsored Trial of Peregrine Pharmaceuticals' Bavituximab in Combination With Pemetrexed and Carboplatin in Front-Line Non-Small Cell Lung Cancer investment picks
By Andria Cheng, MarketWatch NEW YORK (MarketWatch) -- The word from McDonald's Corp.
Sign-up for At McDonald's, the promises have an echo investment picks
NeuroDerm Ltd.
Sign-up for NeuroDerm shares surge 19.6% as Parkinson's treatment shows promise investment picks
NCR Corporation (NYSE: NCR), the global leader in consumer transaction technologies, announced today that it has successfully deployed the NCR venue management solution at Ascot Racecourse, ‘the grand old lady’ of Australian racecourses.
Sign-up for Ascot Racecourse Promises Exceptional Customer Experiences with NCR Venue Management Solution investment picks
SALT LAKE CITY , Nov.
Sign-up for Dynatronics Announces Promising First Quarter Financial Results investment picks
Cytori Therapeutics, Inc. (NASDAQ: CYTX) today reported positive results from a clinical study of Cytori Cell Therapy™ in anterior cruciate ligament (ACL) reconstruction of patients with ACL tears.
Sign-up for Cytori Announces Promising Results in a Feasibility Trial of Cytori Cell Therapy in Conjunction with Anterior Cruciate Ligament Repair investment picks
2014/12/6
- Note: This press release corresponds to abstract 31.
Sign-up for IMBRUVICA® (ibrutinib) Data Suggests Promise in Multiple Myeloma investment picks
By Ron Winslow SAN FRANCISCO--Four patients with a lethal blood disorder were able to forgo life-sustaining blood transfusions within 90 days after they were treated with a technique to replace the defective gene responsible for their disease, researchers said Monday.
Sign-up for Bluebird gene therapy shows promise for lethal blood disease investment picks
Foundation Medicine, Inc. (NASDAQ:FMI) today announced new data demonstrating that its comprehensive genomic profile, FoundationOne® Heme , identified genomic alterations in patients with heavily pre-treated multiple myeloma that informed treatment with trametinib, an FDA-approved targeted therapeutic agent 1 .
Sign-up for Treatment for Relapsed Multiple Myeloma Patients Guided by FoundationOne® Heme Results in Promising Clinical Activity investment picks
- Data Show Significant Survival Improvement with CPX-351 in Poor-Risk Patients - EWING, N.J. , Jan.
Sign-up for Celator® Pharmaceuticals Announces Publication Of Promising Phase 2 Data For CPX-351 In First Relapse Acute Myeloid Leukemia Patients investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Promising Companies
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Projected Total  |  Next: Promising Research